ALLUZIENCE sol inj 125 U/0.625ml flac
7680681450016
CH-68145
M03AX01
01.13.0.
1 / 2
google
Details
- Product number
- 6814501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- complexus toxini botulinici A et haemagglutinini 125 U., histidinum, saccharum, natrii chloridum corresp. natrium 2.156 mg, polysorbatum 80, acidum hydrochloricum q.s. ad pH pro vitro.
Articles (1)
Alluzience, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.156 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
IPSEN Pharma Schweiz GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 68145
- Drug name
- Alluzience, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- M03AX01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/12/2021
- Authorization expiration date
- 09/12/2026
- IT number
- 01.13.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALLUZIENCE sol inj 125 U/0.625ml flac
- Description (DE)
- ALLUZIENCE Inj Lös 125 E/0.625ml Durchstf
- Market launch
- 10/12/2021
- Narcotic (BTM)
- No